7Baggers
 about us  FinancialContent Thu, 16 Oct 2025 21:14:00 GMT
 ALLOVIR INVESTIGATION: Bragar Eagel & Squire, P.C.  GlobeNewswire Thu, 16 Oct 2025 07:00:00 GMT
 about us  FinancialContent Fri, 03 Oct 2025 04:33:10 GMT
 allovir falls after all-stock merger deal with kalaris  MSN Sun, 21 Sep 2025 21:27:35 GMT
 allovir (nasdaq:alvr) trading 0.9% higher – still a buy?  Defense World Thu, 11 Sep 2025 06:22:28 GMT
 allovir (nasdaq:alvr) trading up 1.6% – what’s next?  Defense World Wed, 20 Aug 2025 08:26:36 GMT
 allovir, inc. securities lawsuit investigation  Claim Depot Mon, 11 Aug 2025 02:15:08 GMT
 allovir, inc. securities lawsuit investigation  Claim Depot Sun, 10 Aug 2025 07:00:00 GMT
 allovir alert: bragar eagel & squire, p.c. is investigating  GlobeNewswire Thu, 07 Aug 2025 00:09:00 GMT
 allovir alert: bragar eagel & squire, p.c. is investigating  GlobeNewswire Wed, 06 Aug 2025 07:00:00 GMT
 silicon valley  FinancialContent Wed, 06 Aug 2025 07:00:00 GMT
 allovir (nasdaq:alvr) shares down 2.8% – here’s what happened  Defense World Tue, 29 Jul 2025 07:00:00 GMT
 allovir (nasdaq:alvr) shares down 2.3% – should you sell?  Defense World Sat, 05 Jul 2025 11:45:01 GMT
 allovir (nasdaq:klrs) rating increased to hold at wall street zen  Defense World Tue, 17 Jun 2025 05:37:18 GMT
 allovir, inc. (nasdaq:alvr) stake lowered by two sigma investments lp  Defense World Fri, 13 Jun 2025 07:00:00 GMT
 squarepoint ops llc invests $142,000 in allovir, inc. (nasdaq:alvr)  Defense World Mon, 09 Jun 2025 07:48:37 GMT
 allovir (nasdaq:klrs) cut to sell at wall street zen  Defense World Mon, 09 Jun 2025 07:44:23 GMT
 wall street zen upgrades allovir (nasdaq:klrs) to hold  MarketBeat Thu, 05 Jun 2025 09:21:19 GMT
 allovir (nasdaq:klrs) upgraded to hold at wall street zen  MarketBeat Wed, 04 Jun 2025 01:15:18 GMT
 allovir (nasdaq:klrs) upgraded at wall street zen  MarketBeat Sun, 01 Jun 2025 07:48:19 GMT
 allovir (nasdaq:klrs) upgraded to "hold" at wall street zen  MarketBeat Sun, 01 Jun 2025 07:48:19 GMT
 allovir (nasdaq:klrs) upgraded to “hold” at wall street zen  Defense World Sun, 01 Jun 2025 07:17:08 GMT
 allovir (nasdaq:klrs) rating lowered to sell at wall street zen  Defense World Mon, 26 May 2025 05:41:26 GMT
 kalaris therapeutics, inc. sec 10-q report  TradingView Wed, 14 May 2025 07:00:00 GMT
 ex-99.3  SEC.gov Sun, 11 May 2025 22:02:03 GMT
 press release distribution & pr platform  ACCESS Newswire Fri, 02 May 2025 20:09:35 GMT
 press release distribution & pr platform  ACCESS Newswire Mon, 28 Apr 2025 06:37:21 GMT
 press release distribution & pr platform  ACCESS Newswire Sun, 27 Apr 2025 04:10:50 GMT
 press release distribution & pr platform  ACCESS Newswire Sat, 26 Apr 2025 18:05:05 GMT
 press release distribution & pr platform  ACCESS Newswire Fri, 25 Apr 2025 05:08:21 GMT
 halper sadeh llp, allovir, inc., avid bioservices, inc., emcore corporation  The Bradford Era Thu, 24 Apr 2025 08:09:14 GMT
 press release distribution & pr platform  ACCESS Newswire Sat, 19 Apr 2025 13:21:02 GMT
 hemorrhagic cystitis market growth to accelerate in forecast  openPR Wed, 26 Mar 2025 19:43:00 GMT
 Kalaris and AlloVir Inc. complete merger  Ophthalmology Times Sat, 22 Mar 2025 07:00:00 GMT
 Kalaris Therapeutics Announces Closing of Merger With AlloVir  VisionMonday.com Fri, 21 Mar 2025 07:00:00 GMT
 kalaris therapeutics completes merger with allovir  MarketScreener Wed, 19 Mar 2025 07:00:00 GMT
 kalaris announces closing of merger with allovir  The Manila Times Wed, 19 Mar 2025 07:00:00 GMT
 AlloVir Merges with Kalaris Therapeutics, Inc.  TipRanks Tue, 18 Mar 2025 07:00:00 GMT
 ex-99.3  SEC.gov Tue, 18 Mar 2025 07:00:00 GMT
 allovir, inc. - common stock (nasdaq:alvr) stock quote  FinancialContent Tue, 18 Mar 2025 07:00:00 GMT
 kalaris announces closing of merger with allovir  The Globe and Mail Tue, 18 Mar 2025 07:00:00 GMT
 Kalaris and AlloVir Announce Stockholder Approval of Merger  VisionMonday.com Fri, 14 Mar 2025 07:00:00 GMT
 allovir shareholders approve merger with kalaris therapeutics by investing.com  Investing.com Australia Thu, 13 Mar 2025 03:00:30 GMT
 Kalaris and AlloVir Announce Stockholder Approval of Merger  Yahoo Finance Wed, 12 Mar 2025 07:00:00 GMT
 allovir shareholders approve merger with kalaris therapeutics  Investing.com Wed, 12 Mar 2025 07:00:00 GMT
 allovir stockholders approve key amendment and merger  TipRanks Wed, 12 Mar 2025 07:00:00 GMT
 parainfluenza virus infection clinical and non-clinical  openPR Mon, 10 Mar 2025 16:39:00 GMT
 allovir (alvr) expected to announce earnings on thursday  The AM Reporter Sun, 09 Mar 2025 08:00:00 GMT
 allovir inc. (alvr) reports earnings  Quartz Fri, 07 Mar 2025 13:23:27 GMT
 allovir, inc. sec 10-k report  TradingView Fri, 07 Mar 2025 08:00:00 GMT
 allovir’s chief accounting officer sells $967 in stock  Investing.com India Tue, 25 Feb 2025 08:00:00 GMT
 allovir general counsel edward miller sells $1,068 in stock  Investing.com India Tue, 25 Feb 2025 08:00:00 GMT
 allovir's chief accounting officer sells $967 in stock by investing.com  Investing.com Australia Tue, 25 Feb 2025 01:01:55 GMT
 allovir’s vikas sinha sells shares worth $3,052  Investing.com Mon, 24 Feb 2025 22:02:10 GMT
 allovir's vikas sinha sells shares worth $3,052  Investing.com Mon, 24 Feb 2025 22:02:10 GMT
 allovir general counsel edward miller sells $1,068 in stock  Investing.com India Mon, 24 Feb 2025 21:43:43 GMT
 allovir's chief accounting officer sells $967 in stock  Investing.com Mon, 24 Feb 2025 08:00:00 GMT
 allovir’s vikas sinha sells shares worth $3,052 by investing.com  Investing.com UK Mon, 24 Feb 2025 08:00:00 GMT
 allovir’s chief accounting officer sells $967 in stock by investing.com  Investing.com UK Mon, 24 Feb 2025 08:00:00 GMT
 allovir (nasdaq:alvr) stock price up 0.5% - should you buy?  MarketBeat Wed, 12 Feb 2025 06:48:19 GMT
 silicon valley  FinancialContent Mon, 10 Feb 2025 08:00:00 GMT
 prn_financialwrapper  FinancialContent Mon, 10 Feb 2025 08:00:00 GMT
 user  FinancialContent Mon, 10 Feb 2025 08:00:00 GMT

AlloVir, Inc
(NASDAQ:ALVR) 

ALVR stock logo

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is Viralym-M, an allogeneic, off-the-shelf VST...

Founded: 2013
Full Time Employees: 32
CEO: David L. Hallal  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends